Scynexis has resumed dosing of its vaginal yeast infection drug Brexafemme (ibrexafungerp) in a Phase III trial after a ...

Merck KGaA is filing for global regulatory approvals of pimicotinib after it met primary and secondary endpoints in a Phase ...

The US-based START Center for Cancer Research (START) and OneOncology have collaborated to introduce three early-phase trial ...

Rein Therapeutics has dosed the first subject in a Phase II trial of LTI-03, its lead asset for treating idiopathic pulmonary ...

Gilgamesh managed to overcome the issue of functional unblinding in the study, an obstacle experienced by the psychedelic ...

After Lykos' rejection from the FDA last year, companies trying to navigate the psychedelic drug trial sector face various ...

Edward Owen, Therapeutic Area Director of Oncology and Early Clinical Development at Genentech, discussed clinical trials decarbonisation at CTO West Coast. Credit: Athanasios Psimadis/ Arena ...

The collaboration supports BrainStorm’s preparation for its planned Phase IIIb trial. Credit: Pavel Kapysh / Shutterstock. US-based biotechnology company BrainStorm Cell Therapeutics has partnered ...

The 12th Outsourcing in Clinical Trials UK & Ireland conference will focus on the region’s future as a clinical trials hub.

The FDA ordered a clinical hold on Rocket Pharmaceuticals' Danon disease trial after the adverse event was first disclosed.

Augustine Therapeutics has initiated subject dosing in the randomised Phase I trial of AGT-100216 for Charcot-Marie-Tooth ...

With the 78th World Health Assembly ending today, all eyes have been on this year’s World Health Organization (WHO) member’s ...